Skip to main content

Table 2 Resistance genes that contribute to spatial patterns within the sub-population where metagenomic analysis was performed

From: Investigating potential transmission of antimicrobial resistance in an open-plan hospital ward: a cross-sectional metagenomic study of resistome dispersion in a lower middle-income setting

Gene SS (trace) Pseudo-F p value Explained variance (proportion) Resistance mechanism
OXA-1 66.812 9.953 0.001 0.322 Beta-lactams resistance
mcr-1.9 56.881 7.916 0.004 0.274 Peptide antibiotic resistance
BRP(MBL) 55.229 7.603 0.005 0.266 Beta-lactams resistance
dfrA14 48.845 6.454 0.006 0.235 Diaminopyrimidine resistance
omp38 45.105 5.823 0.011 0.217 Beta-lactams resistance
rmtB 42.099 5.336 0.012 0.203 Aminoglycosides resistance
NDM-7 40.965 5.157 0.016 0.197 Beta-lactams resistance
catB3 40.085 5.020 0.014 0.193 Phenicol resistance
vanSG 37.290 4.593 0.024 0.180 Glycopeptide resistance
tsnR 36.330 4.450 0.017 0.175 Peptide antibiotic resistance
mgtA 36.330 4.450 0.015 0.175 Macrolide resistance
mdfA 36.019 4.404 0.023 0.173 Multidrug efflux pump
kpnF 32.752 3.930 0.037 0.158 Multidrug efflux pump
vanN 32.473 3.890 0.041 0.156 Glycopeptide resistance
vanO 31.383 3.736 0.048 0.151 Glycopeptide resistance
CRP 31.383 3.736 0.049 0.151 Multidrug efflux pump
vgaE 31.383 3.736 0.048 0.151 Streptogramin resistance
fusB 31.309 3.726 0.039 0.151 Fusidic acid resistance
cfxA6 30.898 3.668 0.046 0.149 Beta-lactams resistance
  1. Performed using DISTLM test
  2. SS sum of squares